MPM BioVentures IV QP LP 13D and 13G filings for Syndax Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-12 4:06 pm Sale | 2020-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX | MPM BioVentures IV QP LP | 0 0.000% | -2,242,658 (Position Closed) | Filing |